Follow the people · Insider
Mayukh Sukhatme
Mayukh Sukhatme files insider transactions with the SEC as a president & cio of Roivant Sciences (ROIV). We hold 9 disclosed purchases and sales filed since 22 April 2022, 8 of them in the last 90 days.
- Files forROIV
- Disclosed buys and sells9 in all, 8 in the last 90 days
- Last disclosure21 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 20 April 2022 — 21 August 2026President & CIO · Roivant Sciences (ROIV)82 Form 4 lines · source: SEC Form 4
Everything they disclosed
82 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 172,899 shares of Roivant SciencesSEC Form 421 August 2026Common Shares · traded 19 August 2026 · filed 21 August 2026
- ▼ sold on the open market 172,899 shares of Roivant SciencesSEC Form 421 August 2026Common Shares · traded 19 August 2026 · filed 21 August 2026
- exercised options over 17,519 shares of Roivant SciencesSEC Form 421 August 2026Common Shares · traded 20 August 2026 · filed 21 August 2026
- ▼ sold on the open market 17,519 shares of Roivant SciencesSEC Form 421 August 2026Common Shares · traded 20 August 2026 · filed 21 August 2026
- exercised options over 144,756 shares of Roivant SciencesSEC Form 421 August 2026Common Shares · traded 21 August 2026 · filed 21 August 2026
- ▼ sold on the open market 144,756 shares of Roivant SciencesSEC Form 421 August 2026Common Shares · traded 21 August 2026 · filed 21 August 2026
- exercised options over 172,899 shares of Roivant Sciences (a derivative holding)SEC Form 421 August 2026Stock Option (Right to Buy) · traded 19 August 2026 · filed 21 August 2026
- exercised options over 17,519 shares of Roivant Sciences (a derivative holding)SEC Form 421 August 2026Stock Option (Right to Buy) · traded 20 August 2026 · filed 21 August 2026
- exercised options over 144,756 shares of Roivant Sciences (a derivative holding)SEC Form 421 August 2026Stock Option (Right to Buy) · traded 21 August 2026 · filed 21 August 2026
- exercised options over 243,177 shares of Roivant SciencesSEC Form 418 August 2026Common Shares · traded 14 August 2026 · filed 18 August 2026
- exercised options over 284,707 shares of Roivant Sciences (a derivative holding)SEC Form 418 August 2026Common Shares · traded 17 August 2026 · filed 18 August 2026
- exercised options over 136,942 shares of Roivant Sciences (a derivative holding)SEC Form 418 August 2026Common Shares · traded 18 August 2026 · filed 18 August 2026
- ▼ sold on the open market 243,177 shares of Roivant SciencesSEC Form 418 August 2026Common Shares · traded 14 August 2026 · filed 18 August 2026
- exercised options over 284,707 shares of Roivant SciencesSEC Form 418 August 2026Common Shares · traded 17 August 2026 · filed 18 August 2026
- ▼ sold on the open market 284,707 shares of Roivant SciencesSEC Form 418 August 2026Common Shares · traded 17 August 2026 · filed 18 August 2026
- exercised options over 105,141 shares of Roivant SciencesSEC Form 418 August 2026Common Shares · traded 18 August 2026 · filed 18 August 2026
- ▼ sold on the open market 105,141 shares of Roivant SciencesSEC Form 418 August 2026Common Shares · traded 18 August 2026 · filed 18 August 2026
- exercised options over 31,801 shares of Roivant SciencesSEC Form 418 August 2026Common Shares · traded 18 August 2026 · filed 18 August 2026
- ▼ sold on the open market 31,801 shares of Roivant SciencesSEC Form 418 August 2026Common Shares · traded 18 August 2026 · filed 18 August 2026
- exercised options over 243,177 shares of Roivant Sciences (a derivative holding)SEC Form 418 August 2026Common Shares · traded 14 August 2026 · filed 18 August 2026
- had shares withheld for tax on 46,878 shares of Roivant SciencesSEC Form 42 July 2026Common Shares · traded 30 June 2026 · filed 2 July 2026
- exercised options over 500,000 shares of Roivant SciencesSEC Form 429 June 2026Common Shares · traded 25 June 2026 · filed 29 June 2026
- ▼ sold on the open market 500,000 shares of Roivant SciencesSEC Form 429 June 2026Common Shares · traded 25 June 2026 · filed 29 June 2026
- exercised options over 500,000 shares of Roivant SciencesSEC Form 429 June 2026Common Shares · traded 26 June 2026 · filed 29 June 2026
- ▼ sold on the open market 500,000 shares of Roivant SciencesSEC Form 429 June 2026Common Shares · traded 26 June 2026 · filed 29 June 2026
- exercised options over 500,000 shares of Roivant Sciences (a derivative holding)SEC Form 429 June 2026Stock Option (Right to Buy) · traded 25 June 2026 · filed 29 June 2026
- exercised options over 500,000 shares of Roivant Sciences (a derivative holding)SEC Form 429 June 2026Stock Option (Right to Buy) · traded 26 June 2026 · filed 29 June 2026
- exercised options over 58,391 shares of Roivant SciencesSEC Form 41 April 2026Common Shares · traded 30 March 2026 · filed 1 April 2026
- had shares withheld for tax on 29,809 shares of Roivant SciencesSEC Form 41 April 2026Common Shares · traded 30 March 2026 · filed 1 April 2026
- had shares withheld for tax on 187,512 shares of Roivant SciencesSEC Form 41 April 2026Common Shares · traded 31 March 2026 · filed 1 April 2026
- exercised options over 1,306,889 shares of Roivant Sciences (a derivative holding)SEC Form 41 April 2026Capped Value Appreciation Rights · traded 30 March 2026 · filed 1 April 2026
- exercised options over 651,558 shares of Roivant SciencesSEC Form 411 February 2026Common Shares · traded 9 February 2026 · filed 11 February 2026
- ▼ sold on the open market 339,441 shares of Roivant SciencesSEC Form 411 February 2026Common Shares · traded 9 February 2026 · filed 11 February 2026
- acquired or disposed of, other 312,117 shares of Roivant SciencesSEC Form 411 February 2026Common Shares · traded 9 February 2026 · filed 11 February 2026
- exercised options over 651,558 shares of Roivant Sciences (a derivative holding)SEC Form 411 February 2026Stock Option (Right to Buy) · traded 9 February 2026 · filed 11 February 2026
- exercised options over 651,558 shares of Roivant Sciences (a derivative holding)SEC Form 411 February 2026Stock Option (Right to Buy) · traded 9 February 2026 · filed 11 February 2026
- exercised options over 651,558 shares of Roivant SciencesSEC Form 411 February 2026Common Shares · traded 9 February 2026 · filed 11 February 2026
- ▼ sold on the open market 339,441 shares of Roivant SciencesSEC Form 411 February 2026Common Shares · traded 9 February 2026 · filed 11 February 2026
- acquired or disposed of, other 312,117 shares of Roivant SciencesSEC Form 411 February 2026Common Shares · traded 9 February 2026 · filed 11 February 2026
- exercised options over 748,358 shares of Roivant Sciences (a derivative holding)SEC Form 431 December 2025Stock Option (Right to Buy) · traded 29 December 2025 · filed 31 December 2025
- exercised options over 2,449,877 shares of Roivant Sciences (a derivative holding)SEC Form 431 December 2025Stock Option (Right to Buy) · traded 31 December 2025 · filed 31 December 2025
- exercised options over 748,358 shares of Roivant SciencesSEC Form 431 December 2025Common Shares · traded 29 December 2025 · filed 31 December 2025
- ▼ sold on the open market 311,873 shares of Roivant SciencesSEC Form 431 December 2025Common Shares · traded 29 December 2025 · filed 31 December 2025
- acquired or disposed of, other 436,485 shares of Roivant SciencesSEC Form 431 December 2025Common Shares · traded 29 December 2025 · filed 31 December 2025
- exercised options over 2,449,877 shares of Roivant SciencesSEC Form 431 December 2025Common Shares · traded 31 December 2025 · filed 31 December 2025
- ▼ sold on the open market 1,018,995 shares of Roivant SciencesSEC Form 431 December 2025Common Shares · traded 31 December 2025 · filed 31 December 2025
- acquired or disposed of, other 1,430,882 shares of Roivant SciencesSEC Form 431 December 2025Common Shares · traded 31 December 2025 · filed 31 December 2025
- exercised options over 59,513 shares of Roivant Sciences (a derivative holding)SEC Form 419 December 2025Common Shares · traded 17 December 2025 · filed 19 December 2025
- exercised options over 59,513 shares of Roivant SciencesSEC Form 419 December 2025Common Shares · traded 17 December 2025 · filed 19 December 2025
- ▼ sold on the open market 26,831 shares of Roivant SciencesSEC Form 419 December 2025Common Shares · traded 17 December 2025 · filed 19 December 2025
- acquired or disposed of, other 32,682 shares of Roivant SciencesSEC Form 419 December 2025Common Shares · traded 17 December 2025 · filed 19 December 2025
- exercised options over 10,796 shares of Roivant Sciences (a derivative holding)SEC Form 426 December 2024Stock Option (Right to Buy) · traded 23 December 2024 · filed 26 December 2024
- exercised options over 185,946 shares of Roivant Sciences (a derivative holding)SEC Form 426 December 2024Stock Option (Right to Buy) · traded 24 December 2024 · filed 26 December 2024
- exercised options over 689,495 shares of Roivant Sciences (a derivative holding)SEC Form 426 December 2024Stock Option (Right to Buy) · traded 26 December 2024 · filed 26 December 2024
- exercised options over 10,796 shares of Roivant SciencesSEC Form 426 December 2024Common Shares · traded 23 December 2024 · filed 26 December 2024
- ▼ sold on the open market 10,796 shares of Roivant SciencesSEC Form 426 December 2024Common Shares · traded 23 December 2024 · filed 26 December 2024
- exercised options over 185,946 shares of Roivant SciencesSEC Form 426 December 2024Common Shares · traded 24 December 2024 · filed 26 December 2024
- ▼ sold on the open market 185,946 shares of Roivant SciencesSEC Form 426 December 2024Common Shares · traded 24 December 2024 · filed 26 December 2024
- exercised options over 689,495 shares of Roivant SciencesSEC Form 426 December 2024Common Shares · traded 26 December 2024 · filed 26 December 2024
- ▼ sold on the open market 689,495 shares of Roivant SciencesSEC Form 426 December 2024Common Shares · traded 26 December 2024 · filed 26 December 2024
- exercised options over 412,584 shares of Roivant Sciences (a derivative holding)SEC Form 420 December 2024Stock Option (Right to Buy) · traded 18 December 2024 · filed 20 December 2024
- exercised options over 412,584 shares of Roivant SciencesSEC Form 420 December 2024Common Shares · traded 18 December 2024 · filed 20 December 2024
- ▼ sold on the open market 412,584 shares of Roivant SciencesSEC Form 420 December 2024Common Shares · traded 18 December 2024 · filed 20 December 2024
- acquired or disposed of, other 3,651,985 shares of Roivant SciencesSEC Form 45 December 2024Common Shares · traded 3 December 2024 · filed 5 December 2024
- was granted 1,836,547 shares of Roivant SciencesSEC Form 430 July 2024Common Shares · traded 26 July 2024 · filed 30 July 2024
- was granted 17,000,000 shares of Roivant SciencesSEC Form 430 July 2024Common Shares · traded 26 July 2024 · filed 30 July 2024
- exercised options over 1,856,163 shares of Roivant Sciences (a derivative holding)SEC Form 42 April 2024Capped Value Appreciation Rights · traded 30 March 2024 · filed 2 April 2024
- exercised options over 729,081 shares of Roivant SciencesSEC Form 42 April 2024Common Shares · traded 30 March 2024 · filed 2 April 2024
- had shares withheld for tax on 366,211 shares of Roivant SciencesSEC Form 42 April 2024Common Shares · traded 30 March 2024 · filed 2 April 2024
- exercised options over 159,100 shares of Roivant Sciences (a derivative holding)SEC Form 429 December 2023Capped Value Appreciation Rights · traded 27 December 2023 · filed 29 December 2023
- exercised options over 28,411 shares of Roivant Sciences (a derivative holding)SEC Form 429 December 2023Capped Value Appreciation Rights · traded 27 December 2023 · filed 29 December 2023
- exercised options over 71,365 shares of Roivant SciencesSEC Form 429 December 2023Common Shares · traded 27 December 2023 · filed 29 December 2023
- exercised options over 53,033 shares of Roivant Sciences (a derivative holding)SEC Form 429 September 2023Capped Value Appreciation Rights · traded 27 September 2023 · filed 29 September 2023
- exercised options over 28,411 shares of Roivant Sciences (a derivative holding)SEC Form 429 September 2023Capped Value Appreciation Rights · traded 27 September 2023 · filed 29 September 2023
- exercised options over 27,790 shares of Roivant SciencesSEC Form 429 September 2023Common Shares · traded 27 September 2023 · filed 29 September 2023
- exercised options over 53,033 shares of Roivant Sciences (a derivative holding)SEC Form 429 August 2023Capped Value Appreciation Rights · traded 27 August 2023 · filed 29 August 2023
- exercised options over 22,565 shares of Roivant SciencesSEC Form 429 August 2023Common Shares · traded 27 August 2023 · filed 29 August 2023
- exercised options over 106,067 shares of Roivant Sciences (a derivative holding)SEC Form 431 July 2023Capped Value Appreciation Rights · traded 27 July 2023 · filed 31 July 2023
- exercised options over 43,212 shares of Roivant SciencesSEC Form 431 July 2023Common Shares · traded 27 July 2023 · filed 31 July 2023
- exercised options over 318,199 shares of Roivant Sciences (a derivative holding)SEC Form 431 May 2023Capped Value Appreciation Rights · traded 27 May 2023 · filed 31 May 2023
- exercised options over 99,458 shares of Roivant SciencesSEC Form 431 May 2023Common Shares · traded 27 May 2023 · filed 31 May 2023
- was granted 16,523,184 shares of Roivant Sciences (a derivative holding)SEC Form 422 April 2022Stock Option (Right to Buy) · traded 20 April 2022 · filed 22 April 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.